211 related articles for article (PubMed ID: 10661409)
1. Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses.
Ohtani T; Ishihara K; Atsumi T; Nishida K; Kaneko Y; Miyata T; Itoh S; Narimatsu M; Maeda H; Fukada T; Itoh M; Okano H; Hibi M; Hirano T
Immunity; 2000 Jan; 12(1):95-105. PubMed ID: 10661409
[TBL] [Abstract][Full Text] [Related]
2. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation.
Park SJ; Nakagawa T; Kitamura H; Atsumi T; Kamon H; Sawa S; Kamimura D; Ueda N; Iwakura Y; Ishihara K; Murakami M; Hirano T
J Immunol; 2004 Sep; 173(6):3844-54. PubMed ID: 15356132
[TBL] [Abstract][Full Text] [Related]
3. TNF-alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex.
Bode JG; Schweigart J; Kehrmann J; Ehlting C; Schaper F; Heinrich PC; Häussinger D
J Immunol; 2003 Jul; 171(1):257-66. PubMed ID: 12817006
[TBL] [Abstract][Full Text] [Related]
4. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
[TBL] [Abstract][Full Text] [Related]
5. Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells.
Kim H; Hawley TS; Hawley RG; Baumann H
Mol Cell Biol; 1998 Mar; 18(3):1525-33. PubMed ID: 9488469
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice.
Tebbutt NC; Giraud AS; Inglese M; Jenkins B; Waring P; Clay FJ; Malki S; Alderman BM; Grail D; Hollande F; Heath JK; Ernst M
Nat Med; 2002 Oct; 8(10):1089-97. PubMed ID: 12219085
[TBL] [Abstract][Full Text] [Related]
7. [gp130F759 mouse].
Ishihara K; Hirano T
Nihon Rinsho; 2005 Jan; 63 Suppl 1():68-72. PubMed ID: 15799320
[No Abstract] [Full Text] [Related]
8. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.
Klein C; Wüstefeld T; Assmus U; Roskams T; Rose-John S; Müller M; Manns MP; Ernst M; Trautwein C
J Clin Invest; 2005 Apr; 115(4):860-9. PubMed ID: 15761498
[TBL] [Abstract][Full Text] [Related]
9. Negative regulation of gp130 signalling mediated through tyrosine-757 is not dependent on the recruitment of SHP2.
Fairlie WD; De Souza D; Nicola NA; Baca M
Biochem J; 2003 Jun; 372(Pt 2):495-502. PubMed ID: 12593670
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Stat3 in interleukin-6-induced IgM production in a human B-cell line.
Faris M; Kokot N; Stahl N; Nel AE
Immunology; 1997 Mar; 90(3):350-7. PubMed ID: 9155640
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic abnormalities in mice deficient in gp130-mediated STAT signaling.
Jenkins BJ; Quilici C; Roberts AW; Grail D; Dunn AR; Ernst M
Exp Hematol; 2002 Nov; 30(11):1248-56. PubMed ID: 12423677
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine 759 of the cytokine receptor gp130 is involved in Listeria monocytogenes susceptibility.
Kamimura D; Fu D; Matsuda Y; Atsumi T; Ohtani T; Park SJ; Ishihara K; Hirano T
Genes Immun; 2002 May; 3(3):136-43. PubMed ID: 12070777
[TBL] [Abstract][Full Text] [Related]
13. Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells.
Burdon T; Stracey C; Chambers I; Nichols J; Smith A
Dev Biol; 1999 Jun; 210(1):30-43. PubMed ID: 10364425
[TBL] [Abstract][Full Text] [Related]
14. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
[TBL] [Abstract][Full Text] [Related]
15. Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation.
Ernst M; Inglese M; Waring P; Campbell IK; Bao S; Clay FJ; Alexander WS; Wicks IP; Tarlinton DM; Novak U; Heath JK; Dunn AR
J Exp Med; 2001 Jul; 194(2):189-203. PubMed ID: 11457894
[TBL] [Abstract][Full Text] [Related]
16. The threshold of gp130-dependent STAT3 signaling is critical for normal regulation of hematopoiesis.
Jenkins BJ; Roberts AW; Najdovska M; Grail D; Ernst M
Blood; 2005 May; 105(9):3512-20. PubMed ID: 15650055
[TBL] [Abstract][Full Text] [Related]
17. SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130.
Lehmann U; Schmitz J; Weissenbach M; Sobota RM; Hortner M; Friederichs K; Behrmann I; Tsiaris W; Sasaki A; Schneider-Mergener J; Yoshimura A; Neel BG; Heinrich PC; Schaper F
J Biol Chem; 2003 Jan; 278(1):661-71. PubMed ID: 12403768
[TBL] [Abstract][Full Text] [Related]
18. Requirement of gp130 signaling for the AGM hematopoiesis.
Takizawa M; Nobuhisa I; Igarashi K; Ueno M; Nakashima K; Kitamura T; Taga T
Exp Hematol; 2003 Apr; 31(4):283-9. PubMed ID: 12691915
[TBL] [Abstract][Full Text] [Related]
19. The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.
Fischer P; Lehmann U; Sobota RM; Schmitz J; Niemand C; Linnemann S; Haan S; Behrmann I; Yoshimura A; Johnston JA; Müller-Newen G; Heinrich PC; Schaper F
Biochem J; 2004 Mar; 378(Pt 2):449-60. PubMed ID: 14611646
[TBL] [Abstract][Full Text] [Related]
20. [Abnormal gp130 signaling and autoimmune disease].
Ishihara K; Atsumi T
Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2336-42. PubMed ID: 12518458
[No Abstract] [Full Text] [Related]
[Next] [New Search]
